Hashimoto's thyroiditis is the most common autoimmune condition in the developed world. It affects an estimated 14 million Americans, roughly 80% of them women. The average time from symptom onset to diagnosis may be over a decade - not because it's hard to detect, but because the right test may not be ordered first.
Hashimoto's is an immune-mediated condition in which the body produces antibodies against its own thyroid tissue. Over time, the cumulative damage can reduce thyroid output. But the antibodies can appear years - sometimes a decade - before TSH shifts enough to cross the diagnostic threshold for hypothyroidism. Ordering TSH alone can mean the window for early intervention is essentially invisible.
What Hashimoto's actually is
The two key antibodies are anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TG). TPO antibodies may be present in approximately 95% of Hashimoto's cases; TG antibodies in about 60–80%. Both can be significantly elevated for years while TSH sits comfortably within the reference range. The gland can be under siege before the numbers move.
Symptoms during this subclinical period can be notoriously diffuse: fatigue that doesn't resolve with sleep, intermittent brain fog, cold hands and feet, hair thinning, dry skin, low mood, and irregular cycles. Each symptom in isolation can be easy to attribute to stress, anemia, or depression. Taken together, with a positive antibody result, they may have a name.
Subclinical Hashimoto's may be common and undertreated
Positive TPO antibodies with a normal TSH may affect an estimated 10–15% of women. Most endocrinologists may monitor rather than treat at this stage - but knowing about it can allow you to reduce inflammatory triggers, monitor frequency, and time future interventions appropriately.
Why it can get missed for so long
The diagnostic pathway for thyroid disease is almost universally TSH-first. If TSH is normal, the workup may stop. There is no standard-of-care recommendation to check antibodies in asymptomatic women. The result: antibody-positive Hashimoto's may be caught only when TSH eventually rises - or when a thorough clinician orders a full panel.
The overlap with other conditions compounds the delay. Low ferritin can produce identical fatigue. Perimenopause can overlap precisely with peak Hashimoto's incidence (late 30s to early 50s). Depression and anxiety can precede hypothyroidism in some Hashimoto's patients, which may be because of early disruption to serotonin metabolism. Without antibody testing, each of these can get treated in isolation.
What you can do if antibodies are positive
Selenium
Several randomised trials report that selenium supplementation (200 µg/day of selenomethionine) can reduce TPO antibody titers over 6–12 months. The mechanism may be selenium's role as a cofactor in the antioxidant enzymes that protect thyroid tissue from immune damage. It may be the closest thing to a disease-modifying intervention currently available for subclinical Hashimoto's.
Gluten and the gut connection
The association between Hashimoto's and coeliac disease is well established - both share HLA-DQ2/DQ8 genetic risk factors, and coeliac disease prevalence in Hashimoto's patients may be 3–5× higher than in the general population. The evidence for gluten exclusion in non-coeliac Hashimoto's patients is weaker and contested, but some studies report that antibodies can fall with strict elimination over 6 months.
Monitoring cadence
If antibodies are positive with normal TSH: test TSH and Free T4 every 6–12 months, antibodies annually. If TSH begins trending above 2.5 with symptoms, the conversation about treatment can become more concrete.
The pregnancy consideration
Positive TPO antibodies in pregnancy may be associated with a significantly higher risk of miscarriage, preterm birth, and postpartum thyroiditis. The American Thyroid Association recommends checking TSH and TPO antibodies in the first trimester for anyone with a personal or family history of thyroid disease. A positive result in pregnancy may warrant treatment to keep TSH below 2.5.
